Keever C A, Pekle K, Gazzola M V, Collins N H, Bourhis J H, Gillio A
Bone Marrow Transplantation Service, Memorial Sloan-Kettering Cancer Center, New York 10021.
J Immunol. 1989 Nov 15;143(10):3241-9.
Both IL-3 and IL-4 have multi-CSF activity on early marrow progenitors. We have examined the effect of IL-3 and IL-4 on the differentiation of NK cells from their marrow-derived precursors and have further examined the interactions of these cytokines with IL-2 and IL-1. We tested marrow which had been depleted of mature cells and of E rosette-positive cells (including NK cells) by treatment with soybean lectin and SRBC (SBA-E-BM). The cytolytic activities of the SBA-E-BM samples were tested in 51Cr-release assays after 7 days of liquid culture. K562 targets were used as a measure of NK activity and NK-resistant Daudi targets were used to measure lymphokine-activated killer (LAK) cell activity. Neither NK nor LAK activity was detectable in marrow cultured in medium without cytokines, or in medium containing IL-3, or IL-4 alone. Both of these cytokines were shown to be inhibitory to the IL-2-induced generation of NK and LAK activity from SBA-E-BM at concentrations as low as 1 U/ml. The inhibitory activity of both IL-3 and IL-4 was found to occur early in the marrow cultures, with little or no inhibitory effects seen if added 48 h after IL-2. IL-3 appeared to be specifically inhibitory to NK cell precursors since addition of IL-3 to cultures of PBMC did not inhibit IL-2-induced lytic activities. In contrast, IL-4 was equally inhibitory to the activation of marrow and peripheral blood NK cells by IL-2. Mixing experiments demonstrated that the reduced lytic activity in IL-3 or IL-4 containing marrow cultures were not due to suppression of the NK effectors, nor could marrow cultured in IL-3 or IL-4 serve as targets for IL-2-activated NK cells. Phenotype analysis of the lymphoid cells in marrow cultures containing IL-2 combined with IL-3 or IL-4 revealed fewer cells expressing Leu-11 (CD16), or Leu-19 (CD56) and fewer CD16, CD56 coexpressing cells compared with marrow cultured in medium containing IL-2 alone. The inhibitory activity of IL-4, but not IL-3, could be partially reversed if IL-1 was added to the cultures, suggesting that IL-1 and IL-4 have opposing activities on NK cells responsiveness to IL-2. These interactions between cytokines might be important in the regulation of NK cell differentiation and on the functional activity of mature NK cells.
白细胞介素-3(IL-3)和白细胞介素-4(IL-4)对早期骨髓祖细胞均具有多集落刺激因子活性。我们研究了IL-3和IL-4对源自骨髓的自然杀伤细胞(NK细胞)前体细胞分化的影响,并进一步研究了这些细胞因子与IL-2和IL-1的相互作用。我们检测了经大豆凝集素和绵羊红细胞(SBA-E-BM)处理后已去除成熟细胞和E花环阳性细胞(包括NK细胞)的骨髓。在液体培养7天后,通过51Cr释放试验检测SBA-E-BM样本的细胞溶解活性。使用K562靶细胞来衡量NK活性,使用对NK有抗性的Daudi靶细胞来衡量淋巴因子激活的杀伤(LAK)细胞活性。在无细胞因子的培养基中培养的骨髓、或仅含IL-3或IL-4的培养基中培养的骨髓中,均未检测到NK或LAK活性。已表明,这两种细胞因子在低至1 U/ml的浓度下,均能抑制IL-2诱导的SBA-E-BM产生NK和LAK活性。发现IL-3和IL-4的抑制活性在骨髓培养早期就会出现,如果在IL-2加入48小时后添加,则几乎没有抑制作用。IL-3似乎对NK细胞前体具有特异性抑制作用,因为向外周血单个核细胞(PBMC)培养物中添加IL-3不会抑制IL-2诱导的溶解活性。相比之下,IL-4对IL-2激活骨髓和外周血NK细胞具有同等抑制作用。混合实验表明,含IL-3或IL-4的骨髓培养物中溶解活性降低,并非由于NK效应细胞受到抑制,且在IL-3或IL-4中培养的骨髓也不能作为IL-2激活的NK细胞的靶细胞。对含IL-2并联合IL-3或IL-4的骨髓培养物中的淋巴细胞进行表型分析发现,与仅在含IL-2的培养基中培养的骨髓相比,表达Leu-11(CD16)或Leu-19(CD56)的细胞较少,且共表达CD16、CD56的细胞也较少。如果在培养物中加入IL-1,IL-4(而非IL-3)的抑制活性可部分逆转,这表明IL-1和IL-4对NK细胞对IL-2的反应性具有相反的作用。细胞因子之间的这些相互作用可能在NK细胞分化调节以及成熟NK细胞的功能活性方面具有重要意义。